Aurinia Pharma (AUPH.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov4

Analyst Miehm Gives Aurinia Pharmaceuticals a Modest Buy Rating

21:56

Aurinia Pharma released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 73.47 M (forecast USD 67.7 M), actual EPS USD 0.23 (forecast USD 0.16)

14:30

Aurinia Pharma released FY2025 9 Months Earnings on November 4 Pre-Market (EST), with actual revenue of USD 205.94 M and EPS of USD 0.5495

14:30

Aurinia Pharmaceuticals Reports Q3 Financial Results

11:00

Nov3

Aurinia Pharmaceuticals Expects EPS of 16 Cents

13:46

Sep30

Aurinia Pharmaceuticals Responds to FDA's Post About Drug Withdrawal

00:27

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 73.47 M, Net Income 31.55 M, EPS 0.23

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 70.01 M, Net Income 21.51 M, EPS 0.1595

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 62.47 M, Net Income 23.34 M, EPS 0.16

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change